abstract |
The invention relates to compounds of formula (I) wherein the substituents are described in claim 1. The compounds can be used in the treatment of diseases based on the glycine capture inhibitor, such as psychoses, pain , neurodegenerative dysfunction of memory and learning, schizophrenia, dementia, and other diseases in which cognitive processes are impaired, such as impaired blood pressure disorders or Alzheimer's disease. |